Cardiogenic Shock Working Group Registry
Tufts Medical Center
5,000 participants
Dec 4, 2017
OBSERVATIONAL
Conditions
Summary
The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Eligibility
Inclusion Criteria10
- Patients must have cardiogenic shock.
- Cardiogenic shock is defined by at least one of the two categories below:
- At least 2 of the following concurrently at any point during the index hospitalization:
- Cardiac Index \< 2.2
- PAPI \< 1.0
- Cardiac Power Output ≤ 0.6
- MAP \< 60mmHg or a \>30mmHg drop in MAP from baseline
- SBP \< 90mmHg or a \>30mmHg drop in SBP from baseline
- Pulse \> 100
- Require at least one acute mechanical circulatory support device, vasopressor or inotrope to maintain values above the above target.
Interventions
The vasopressors include phenylephrine, norepinephrine, epinephrine, dopamine and vasopressin.
Inotropes include dobutamine and milrinone.
Acute Mechanical Circulatory Support devices include ECMO (VV), ECMO (VA), Impella CP, Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, IABP, Centrimag, Tandem Heart and ProTek Duo.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04682483